World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
111
Citations
42122
World Ranking
480
National Ranking
42

Medicine

D-Index
112
Citations
42307
World Ranking
5179
National Ranking
512

Ian Kimber publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ian Kimber sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 787 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ian Kimber D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ian Kimber sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 111 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2016 - Member of Academia Europaea

Overview

Ian Kimber is affiliated with the University of Manchester in the United Kingdom. Their research primarily focuses on the field of medicine, with significant contributions in dermatology, immunology and allergy, small animals, physiology, and plant science. The scientist's work engages deeply with topics related to contact dermatitis and allergies, animal testing and alternatives, allergic rhinitis and sensitization, food allergy and anaphylaxis research, pesticide exposure and toxicity, occupational exposure and asthma, and CAR-T cell therapy research.

Kimber has published extensively in several academic venues, notably contributing to Regulatory Toxicology and Pharmacology, Critical Reviews in Toxicology, Human Gene Therapy, Toxicology Letters, and Frontiers in Molecular Neuroscience. The majority of published work appears in Regulatory Toxicology and Pharmacology.

Recent papers by Ian Kimber include:

  • Determination of the relative allergenic potency of proteins: hurdles and opportunities, 2020, Critical Reviews in Toxicology
  • Reference Chemical Potency List (RCPL): A new tool for evaluating the accuracy of skin sensitisation potency measurements by New Approach Methodologies (NAMs), 2022, Regulatory Toxicology and Pharmacology
  • Enzymes and sensitization via skin exposure: A critical analysis, 2021, Regulatory Toxicology and Pharmacology
  • Specificity of the local lymph node assay (LLNA) for skin sensitisation, 2023, Regulatory Toxicology and Pharmacology
  • Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article, 2024, Human Gene Therapy

Frequent co-authors collaborating with Ian Kimber include Amaia Irizar, Peter Griem, Andreas Natsch, Hans Bender, and Matthias Vey. These collaborations highlight a multidisciplinary approach within allied research areas.

Kimber's research themes cover a broad spectrum of medical topics, with particular emphasis on allergic reactions and toxicity assessments relevant to human health and safety. Contact dermatitis and allergies feature prominently as a central research interest, supported by studies investigating allergenic protein potency, skin sensitization assays, and risk factors associated with therapeutic interventions such as gene therapies.

In recognition of their academic contributions, Ian Kimber was named a Member of Academia Europaea in 2016, reflecting involvement in the broader scientific community.

Best Publications

  • Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization.

    David W. Roberts;Grace Patlewicz;Petra S. Kern;Frank Gerberick

  • Immunogenicity of therapeutic proteins: Influence of aggregation

    Kirsty D. Ratanji;Jeremy P. Derrick;Rebecca J. Dearman;Ian Kimber

  • Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

    Sarah Adler;David Basketter;Stuart Creton;Olavi Pelkonen

  • Food processing and allergenicity

    Kitty C.M. Verhoeckx;Yvonne M. Vissers;Joseph L. Baumert;Roland Faludi

  • Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration.

    M Cumberbatch;R J Dearman;I Kimber

  • Assessment of the safety of foods derived from genetically modified (GM) crops

    A. König;A. Cockburn;R.W.R. Crevel;E. Debruyne

  • Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods

    G. Frank Gerberick;Cindy A. Ryan;Petra S. Kern;Harald Schlatter

  • Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration.

    M Cumberbatch;I Kimber

  • The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma

    L. M. Hamilton;C. Torres-Lozano;S. M. Puddicombe;A. Richter

  • Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects Current knowledge assembled at an international workshop at BfR, Germany

    M. Peiser;T. Tralau;J. Heidler;A. M. Api

  • Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.

    Louisa K. James;Mohamed H. Shamji;Samantha M. Walker;Duncan R. Wilson

  • The murine local lymph node assay: a commentary on collaborative studies and new directions.

    I. Kimber;D.A. Basketter

  • A murine local lymph node assay for the identification of contact allergens. Assay development and results of an initial validation study

    I. Kimber;C. Weisenberger

  • Why Are Some Proteins Allergens

    Russell D. J. Huby;Rebecca J. Dearman;Ian Kimber

  • Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization.

    M Cumberbatch;I Kimber

  • The local lymph node assay: developments and applications.

    I. Kimber;R.J. Dearman;E.W. Scholes;D.A. Basketter

  • The effects of ultraviolet radiation on the human immune system

    M S Duthie;I Kimber;M Norval

  • Classification of contact allergens according to potency: proposals.

    I Kimber;D.A Basketter;M Butler;A Gamer

  • A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses.

    David A. Basketter;Linda J Lea;Andrea Dickens;David Briggs

  • Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy

    M. H. Shamji;C. Ljørring;J. N. Francis;M. A Calderon

  • Use of the local lymph node assay for the estimation of relative contact allergenic potency.

    D. A. Basketter;L. Blaikie;R. J. Dearman;I. Kimber

Frequent Co-Authors

Rebecca J. Dearman
Rebecca J. Dearman University of Manchester
David A. Basketter
David A. Basketter University of Bedfordshire
Marie Cumberbatch
Marie Cumberbatch AstraZeneca (United Kingdom)
Cindy A. Ryan
Cindy A. Ryan Procter & Gamble (United States)
G. Frank Gerberick
G. Frank Gerberick Procter & Gamble (United States)
Christopher E.M. Griffiths
Christopher E.M. Griffiths University of Manchester
John Ashby
John Ashby Syngenta (Switzerland)
Michael Moore
Michael Moore Plymouth Marine Laboratory
Nancy J. Rothwell
Nancy J. Rothwell University of Manchester
Mary Norval
Mary Norval University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often opens doors to various allied health and nursing careers, especially in the United States. Many students consider expanding their expertise by enrolling in specialized programs that complement their background in immunology and healthcare.

For those interested in advancing their clinical skills, acnp programs offer a strong pathway to become Acute Care Nurse Practitioners. These specialized programs equip learners with the knowledge needed to manage complex care situations in hospital settings.

If you are looking to accelerate your career, several reputable accelerated nurse practitioner program options are available online. These programs provide a fast-tracked education route, especially beneficial for those switching careers or seeking advanced qualifications without extended timelines.

For individuals without prior nursing experience, exploring online nursing programs for non nurses can be an excellent start. These programs help beginners build foundational nursing skills remotely, allowing for flexible learning schedules.

Finally, for those aiming to earn a Bachelor of Science in Nursing (BSN) quickly, the easiest accelerated nursing programs to get into provide accessible entry points without compromising quality, perfect for motivated students balancing other commitments.

Best Scientists Citing Ian Kimber

Trending Scientists

Recently Published Articles